Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15cdb7f194f7833bb67887dbd19b4040 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-00472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-0054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-0091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-00748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-00468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-00106 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00991 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-44 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-60 |
filingDate |
2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b64ce61905a64469fdb5b86182de4134 |
publicationDate |
2012-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2497503-A1 |
titleOfInvention |
Haemostatic wound care article |
abstract |
The invention relates to a wound care article comprising an amount of superabsorbent polymers. The wound care article is characterized in that it has at least one agent which can restrict the bleeding or bleeding tendency. This may be a chemically and / or pharmacologically and / or physiologically acting active substance or active substance complex and / or a physically acting active element ( Fig. 5 ). |
priorityDate |
2007-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |